Dr. Andre C. Kalil, MD

Dr. Kalil practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Kalil's NPI, 1265480750, was assigned on May 5, 2006. Dr. Kalil holds Nebraska license 22331.

Dr. Kalil's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Kalil also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Kalil's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. The medical group on file is UNMC Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalil practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Kalil's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Kalil is licensed in Nebraska.

CMS data shows 374 Medicare services from Dr. Kalil across 3 procedure codes in 2024, for 80 Medicare patients. Medicare paid $32,470 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Kalil in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 3.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalil's median patient age at 62, with 39% women.

In 2024, Dr. Kalil wrote 40 Medicare Part D claims. 93% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $9,897 in total drug cost. In 2021, CMS named 52 claims across 3 drugs.

Dr. Kalil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalil as offering telehealth.

Dmand AI links 140 papers to Dr. Kalil, published from 2016 to 2025. 2024 was the busiest year, with 14. The most frequent topics are COVID-19, Anti-Bacterial Agents and SARS-CoV-2. Dr. Kalil has published most often in Crit Care Med. Dr. Kalil's most frequent co-authors are Daniel Anthony Sweeney, MD, Kelly A. Cawcutt, MD and Mark L. Metersky, MD.

CMS Open Payments shows 11 general payments to Dr. Kalil from 4 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 56% of the total. Moderna TX, Inc. paid the most, $4,110.